Cover Image

An Adaptive Three‐Arm Comparative Clinical Endpoint Bioequivalence Study Design With Unblinded Sample Size Re‐Estimation and Optimized Allocation Ratio

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	David Hinds, Wanjie Sun
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pharmaceutical Statistics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multiplicity Adjustment Methods for a Three‐Way Crossover Bioequivalence Study
by: David Hinds, et al.
Published: (2026)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
by: Go Horiguchi, et al.
Published: (2026)

A Flexible Seamless Phase 2/3 Design With Biomarker‐Driven Subgroup Enrichment and Sample Size Re‐Estimation
by: Zizhong Tian, et al.
Published: (2025)

Comparative Analyses of Bioequivalence Assessment Methods for In Vitro Permeation Test Data
by: Sami Leon, et al.
Published: (2024)

Variable Duration Trial as an Alternative Design for Continuous Endpoints
by: Jitendra Ganju, et al.
Published: (2024)

Utility‐Based Dose Optimization Approaches for Multiple‐Dose Randomized Trial Designs Accounting for Multiple Endpoints
by: Gina D'Angelo, et al.
Published: (2025)

Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
by: Xiaolong Luo, et al.
Published: (2025)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
by: Zhiwei Zhang, et al.
Published: (2025)

Sample Size Estimation Using a Partially Clustered Frailty Model for Biomarker‐Strategy Designs With Multiple Treatments
by: Derek Dinart, et al.
Published: (2024)

Sample Size Estimation for Correlated Count Data With Changes in Dispersion
by: Jintong Hou, et al.
Published: (2025)

Correction to “Sample Size Estimation for Correlated Count Data With Changes in Dispersion”
Published: (2025)

A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design
by: Qingyang Zhang, et al.
Published: (2025)

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials
by: Yueyang Han, et al.
Published: (2025)

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
by: Yingjie Qiu, et al.
Published: (2024)

A Federated Data Analysis Approach for the Evaluation of Surrogate Endpoints
by: Dries De Witte, et al.
Published: (2025)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
by: Anders Granholm, et al.
Published: (2025)

Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint
by: Ronan Fougeray, et al.
Published: (2024)

Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data
by: Max Menssen, et al.
Published: (2025)

Phase III Probability of Success When Early Development Is Based on a Putative Surrogate Endpoint: A Vaccine Efficacy Case Study
by: Andrea Callegaro, et al.
Published: (2026)

Consistency Assessment and Regional Sample Size Calculation for MRCT Under Random Effects Model
by: Xinru Ren, et al.
Published: (2026)

Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective
by: Ping Gao, et al.
Published: (2025)

Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources
by: Keita Takahashi, et al.
Published: (2025)

Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space
by: Yulia Dyachkova, et al.
Published: (2024)

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
by: Vahan Aslanyan, et al.
Published: (2024)

A Likelihood Perspective on Dose‐Finding Study Designs in Oncology
by: Zhiwei Zhang
Published: (2024)

A Bayesian Hybrid Design With Borrowing From Historical Study
by: Zhaohua Lu, et al.
Published: (2024)

Detection of Outlying Correlation Coefficients in Multicenter Clinical Trials
by: Lieven Desmet, et al.
Published: (2025)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
by: Konstantinos Sechidis, et al.
Published: (2024)

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit
by: Yan Han, et al.
Published: (2025)

Reparametrized Firth's Logistic Regressions for Dose‐Finding Study With the Biased‐Coin Design
by: Hyungwoo Kim, et al.
Published: (2024)

An Association Test for Ordinal Outcomes in Clustered Data With Informative Cluster Size
by: Hasika K. Wickrama Senevirathne, et al.
Published: (2026)

Comparing various Bayesian random‐effects models for pooling randomized controlled trials with rare events
by: Minghong Yao, et al.
Published: (2024)

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose
by: Hao Sun, et al.
Published: (2024)

A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology
by: Jun Zhang, et al.
Published: (2024)

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies
by: Chiara Micoli, et al.
Published: (2025)

Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding
by: Douglas Faries, et al.
Published: (2024)

Using Propensity Score Weighting to Enhance the Operating Characteristics of Power Prior in Leveraging External Data to Augment a Traditional Clinical Study
by: Heng Li, et al.
Published: (2025)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
by: Ryo Kitabayashi, et al.
Published: (2025)

Sample size calculation for comparing two ROC curves
by: Sin‐Ho Jung
Published: (2024)

New, Shorter Small‐Sample Intervals for Vaccine Efficacy
by: Mauro Gasparini, et al.
Published: (2026)